University of California Irvine

University of California Irvine was paid $16.83M by Medicaid between Jan 2018 and Dec 2024, across 334 billing codes. Its largest line is 74176, Computed tomography, abdomen and pelvis; without contrast material — 8.1% of everything it billed.

33Billing provider infoUNIVERSITY OF CALIFORNIA IRVINE
FOUNTAIN VALLEY, CA 92708

33aNPI1821002007assigned 07/27/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$16.83M

24GClaims1,433,110

24DCodes billed334

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#137 of 410

Median peer was paid$6.90M

This provider vs. median2.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	228,726	$1.63M
2019	239,289	$2.05M
2020	203,946	$2.46M
2021	248,175	$2.58M
2022	235,887	$2.70M
2023	174,287	$2.70M
2024incomplete	102,800	$2.71M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
74176	Computed tomography, abdomen and pelvis; without contrast material	8.1%	18,737	16,458	$1.36M
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	7.2%	30,343	17,525	$1.21M
0450	Emergency room services	6.7%	111,342	94,815	$1.13M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	4.3%	21,491	17,400	$720K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	3.5%	3,113	2,964	$596K
70450	Computed tomography, head or brain; without contrast material	3.5%	14,356	12,831	$593K
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	3.5%	2,669	1,920	$592K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	3.5%	27,057	21,682	$589K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	2.9%	4,927	4,611	$484K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	2.2%	34,406	28,430	$365K
96375	Therapeutic injection; each additional sequential IV push	2.0%	16,089	12,563	$338K
71045	Radiologic examination, chest; single view	1.6%	40,218	34,720	$267K

322 more codes

80053	Comprehensive metabolic panel	1.6%	49,379	$263K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.5%	6,407	$260K
96361	Intravenous infusion, hydration; each additional hour	1.5%	15,689	$258K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	1.5%	15,390	$246K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.3%	5,120	$221K
99199	Unlisted special service, procedure or report	1.3%	4,387	$213K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	1.1%	2,952	$189K
76705	Ultrasound, abdominal, real time with image documentation; limited	1.1%	6,238	$181K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.0%	2,453	$173K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	4,951	$165K
72125	Computed tomography, cervical spine; without contrast material	<1%	2,498	$159K
L8699	Prosthetic implant, not otherwise specified	<1%	170	$148K
J3490	Unclassified drugs	<1%	50,454	$146K
C1776	Joint device (implantable)	<1%	171	$145K
83880		<1%	9,127	$141K
Z7502		<1%	3,695	$139K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	37,990	$137K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,772	$133K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	4,902	$132K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	4,407	$130K
J7030	Infusion, normal saline solution , 1000 cc	<1%	26,795	$124K
Z9725		<1%	2,754	$119K
72131		<1%	1,867	$117K
85027		<1%	38,303	$113K
93971		<1%	1,534	$110K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	32,148	$108K
59025	Fetal non-stress test	<1%	7,606	$106K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	2,741	$102K
84484		<1%	21,818	$100K
J2704	Injection, propofol, 10 mg	<1%	19,962	$98K
76801		<1%	2,473	$96K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,241	$86K
0270		<1%	43,840	$83K
71250		<1%	1,297	$81K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	4,912	$80K
J1170	Injection, hydromorphone, up to 4 mg	<1%	13,407	$78K
J0690	Injection, cefazolin sodium, 500 mg	<1%	15,854	$75K
83690		<1%	21,830	$74K
97597		<1%	2,925	$74K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	15,235	$74K
99285	Emergency room visit (most serious)	<1%	3,263	$72K
71275	Computed tomographic angiography, chest, with contrast material	<1%	620	$72K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	13,483	$71K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	20,632	$71K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	18,672	$71K
80048	Basic metabolic panel (calcium, ionized)	<1%	17,709	$70K
81001		<1%	47,325	$69K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	2,893	$69K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	1,265	$68K
76830	Ultrasound, transvaginal	<1%	1,698	$67K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	3,644	$59K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	1,418	$58K
C1769	Guide wire	<1%	444	$55K
A9270	Non-covered item or service	<1%	5,793	$54K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	335	$52K
94664		<1%	7,371	$49K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	7,356	$46K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	12,246	$45K
99283	Emergency room visit (moderate)	<1%	8,450	$45K
0160		<1%	5,538	$43K
81025		<1%	20,138	$43K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	8,518	$41K
93017		<1%	3,234	$40K
73564		<1%	2,480	$40K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	5,189	$38K
85610		<1%	22,513	$38K
C1781	Mesh (implantable)	<1%	1,105	$38K
90715		<1%	1,555	$34K
J7050	Infusion, normal saline solution, 250 cc	<1%	10,899	$33K
73630		<1%	2,461	$33K
87088		<1%	9,760	$33K
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	4,350	$32K
99284	Emergency room visit (serious)	<1%	3,870	$32K
G0378	Hospital observation service, per hour	<1%	231	$32K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	979	$32K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	6,742	$31K
93458		<1%	167	$29K
73610		<1%	2,104	$29K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	9,623	$28K
29881		<1%	572	$27K
87040		<1%	4,664	$27K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	444	$27K
87077		<1%	5,314	$27K
73030		<1%	2,133	$26K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	6,756	$26K
83605		<1%	5,254	$26K
74018		<1%	2,735	$24K
80047		<1%	8,192	$24K
36561		<1%	358	$23K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	262	$23K
93970		<1%	275	$22K
97802		<1%	332	$22K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	563	$21K
J1644	Injection, heparin sodium, per 1000 units	<1%	5,640	$21K
87400		<1%	4,833	$21K
47562		<1%	303	$21K
97803		<1%	1,320	$21K
82962		<1%	15,173	$21K
87070		<1%	4,977	$20K
A4217	Sterile water/saline, 500 ml	<1%	4,871	$19K
85730		<1%	8,360	$19K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	5,503	$19K
73110		<1%	1,392	$19K
84702		<1%	2,795	$18K
87186		<1%	4,026	$18K
73130		<1%	1,298	$18K
72110		<1%	844	$17K
80306		<1%	1,794	$17K
84443	Thyroid stimulating hormone (TSH)	<1%	2,293	$16K
0011A		<1%	397	$16K
96376		<1%	3,280	$14K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	1,164	$14K
71046	Radiologic examination, chest; 2 views	<1%	1,382	$14K
87430		<1%	3,033	$14K
0012A		<1%	337	$13K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,302	$13K
72050		<1%	699	$13K
77001		<1%	402	$13K
80076		<1%	4,857	$12K
49083		<1%	694	$11K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,307	$11K
83735		<1%	4,163	$11K
85379		<1%	2,294	$11K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	296	$11K
97161		<1%	805	$10K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	1,131	$10K
49650		<1%	183	$10K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,907	$10K
36430		<1%	617	$10K
87081		<1%	3,241	$9K
Z7506		<1%	55	$9K
72100		<1%	565	$9K
70486		<1%	183	$9K
86850		<1%	4,963	$8K
10060		<1%	838	$8K
J2060	Injection, lorazepam, 2 mg	<1%	2,171	$8K
86901		<1%	5,117	$8K
86900		<1%	5,113	$8K
S0077	Injection, clindamycin phosphate, 300 mg	<1%	778	$8K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,099	$7K
J3370	Injection, vancomycin hcl, 500 mg	<1%	867	$7K
73080		<1%	568	$7K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	643	$7K
70490		<1%	85	$7K
29826		<1%	151	$6K
Q9968	Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg	<1%	17	$6K
86923		<1%	396	$6K
J1815	Injection, insulin, per 5 units	<1%	1,105	$6K
0760		<1%	1,541	$6K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	194	$6K
74240		<1%	64	$6K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	1,707	$5K
0360		<1%	26,473	$5K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	475	$5K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	156	$5K
73502		<1%	333	$5K
C1760	Closure device, vascular (implantable/insertable)	<1%	166	$5K
12001		<1%	784	$5K
11045		<1%	916	$5K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	847	$5K
J8499	Prescription drug, oral, non chemotherapeutic, nos	<1%	5,866	$5K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,005	$5K
88112		<1%	159	$5K
J0153	Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)	<1%	467	$5K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	261	$5K
29876		<1%	105	$4K
S0164	Injection, pantoprazole sodium, 40 mg	<1%	575	$4K
84439		<1%	959	$4K
36821		<1%	111	$4K
84145		<1%	340	$4K
0762		<1%	1,899	$3K
29827		<1%	79	$3K
76937		<1%	363	$3K
73590		<1%	316	$3K
86140		<1%	1,207	$3K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	57	$3K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,078	$3K
73140		<1%	339	$3K
76942		<1%	176	$3K
A9505	Thallium tl-201 thallous chloride, diagnostic, per millicurie	<1%	145	$3K
12011		<1%	268	$2K
0710		<1%	16,971	$2K
76770		<1%	87	$2K
73560		<1%	235	$2K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	26	$2K
86920		<1%	93	$2K
97001		<1%	139	$2K
73090		<1%	253	$2K
0232T		<1%	156	$2K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	80	$2K
76870		<1%	55	$2K
84100		<1%	1,049	$2K
80061	Lipid panel	<1%	605	$2K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	264	$2K
0250		<1%	5,539	$2K
36415	Collection of venous blood by venipuncture	<1%	401	$2K
Z7512		<1%	55	$2K
71101		<1%	97	$2K
88313		<1%	197	$1K
85014		<1%	5,904	$1K
0272		<1%	7,388	$1K
72128		<1%	20	$1K
84703		<1%	560	$1K
12002		<1%	175	$1K
97162		<1%	70	$1K
87420		<1%	777	$1K
88314		<1%	57	$1K
0370		<1%	1,480	$1K
70498		<1%	12	$1K
C1750	Catheter, hemodialysis/peritoneal, long-term	<1%	76	$989.93
27447		<1%	18	$962.90
94760		<1%	480	$952.79
80305		<1%	174	$933.66
94060		<1%	194	$916.80
29125		<1%	392	$915.38
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	141	$898.53
J1650	Injection, enoxaparin sodium, 10 mg	<1%	92	$881.32
94729		<1%	169	$864.59
82550		<1%	310	$836.74
74241		<1%	12	$817.04
97139		<1%	43	$790.83
J2550	Injection, promethazine hcl, up to 50 mg	<1%	240	$763.73
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	121	$756.55
87147		<1%	224	$701.51
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	238	$681.66
94727		<1%	183	$661.60
58563		<1%	18	$660.00
64721		<1%	30	$643.78
51702		<1%	156	$580.18
J1940	Injection, furosemide, up to 20 mg	<1%	181	$575.34
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	84	$560.43
58558		<1%	30	$522.24
77012		<1%	38	$513.48
71010		<1%	241	$479.72
J3360	Injection, diazepam, up to 5 mg	<1%	33	$455.88
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,144	$404.78
J3486	Injection, ziprasidone mesylate, 10 mg	<1%	20	$382.34
82805		<1%	47	$347.52
84550		<1%	184	$347.21
85384		<1%	82	$347.13
72170		<1%	75	$344.53
72040		<1%	18	$339.60
87116		<1%	80	$334.55
82140		<1%	53	$297.29
83518		<1%	72	$290.64
J1956	Injection, levofloxacin, 250 mg	<1%	48	$279.20
71020		<1%	21	$274.67
82728		<1%	91	$269.71
87210		<1%	168	$265.38
88304		<1%	64	$246.86
76098		<1%	44	$230.21
88331		<1%	55	$217.35
87205		<1%	148	$202.99
87102		<1%	60	$192.50
J1171	Injection, hydromorphone, 0.1 mg	<1%	44	$167.17
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	29	$162.32
11043		<1%	49	$159.01
82570		<1%	58	$157.07
73620		<1%	27	$151.57
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	14	$150.70
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	141	$149.60
94200		<1%	170	$129.94
87206		<1%	81	$122.62
J3105	Injection, terbutaline sulfate, up to 1 mg	<1%	34	$122.17
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	14	$118.45
90686		<1%	17	$117.45
74000		<1%	32	$112.91
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	25	$109.16
0300		<1%	20,152	$107.60
88311		<1%	75	$106.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	201	$90.90
83615		<1%	36	$88.41
85347		<1%	19	$81.62
85651		<1%	77	$80.90
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	656	$80.36
84156		<1%	41	$72.61
0510		<1%	718	$71.31
J0461	Injection, atropine sulfate, 0.01 mg	<1%	13	$70.18
J3475	Injection, magnesium sulfate, per 500 mg	<1%	13	$56.04
88300		<1%	59	$48.62
A4216	Sterile water, saline and/or dextrose, diluent/flush, 10 ml	<1%	754	$43.56
73060		<1%	12	$41.35
29515		<1%	12	$39.90
85652		<1%	30	$33.77
82248		<1%	16	$21.18
A9150	Non-prescription drugs	<1%	2,267	$18.31
81003		<1%	12	$13.20
99001		<1%	70	$10.89
85007		<1%	13	$8.43
J1630	Injection, haloperidol, up to 5 mg	<1%	63	$4.53
89050		<1%	13	$2.84
0258		<1%	956	$0.93
0480		0%	63	$0.00
G9656	Patient transferred directly from anesthetizing location to pacu or other non-icu location	0%	426	$0.00
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	0%	29	$0.00
0402		0%	940	$0.00
0361		0%	229	$0.00
99215	Doctor's office visit, returning patient (complex)	0%	354	$0.00
0460		0%	109	$0.00
0320		0%	3,391	$0.00
0274		0%	85	$0.00
99354		0%	12	$0.00
0481		0%	18	$0.00
0921		0%	57	$0.00
0278		0%	360	$0.00
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	29	$0.00
0489		0%	54	$0.00
S5010	5% dextrose and 0.45% normal saline, 1000 ml	0%	21	$0.00
0636		0%	3,642	$0.00
0761		0%	292	$0.00
G0008	Administration of influenza virus vaccine	0%	14	$0.00
0271		0%	213	$0.00
0255		0%	237	$0.00
0341		0%	42	$0.00
0410		0%	658	$0.00
0610		0%	19	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	62	$0.00
0350		0%	1,873	$0.00
0391		0%	14	$0.00
0310		0%	35	$0.00
99241		0%	19	$0.00
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	0%	236	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSIWABESSY, RANDOLPH (VICE PRESIDENT AND CHIEF FINANCIAL)

Parent organizationUNIVERSITY OF CALIFORNIA IRVI

Same official

Other billing entities under SIWABESSY, RANDOLPH

Full network →

Provider	Location	Paid
University of California Irvine	Orange, CA	$153.06M
University of California Irvine	Lakewood, CA	$21.51M
University of California Irvine	Placentia, CA	$6.87M
University of California Irvine	Los Alamitos, CA	$6.02M
Uc Regents	Fountain Valley, CA	$39K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.